<?xml version="1.0" encoding="UTF-8"?>
<fig id="pharmaceuticals-13-00283-f010" orientation="portrait" position="float">
 <label>Figure 10</label>
 <caption>
  <p>Underlying mechanisms of CHP and CHL exerts and their anti-senescent activity in SH-SY5Y cells. (
   <bold>a</bold>) In hyperglycemia, hyperphosphorylation of Rb induced by high glucose and cyclin D1 caused cell cycle arrest at G1. Hyperphosphorylated Rb failed to assemble with E2F. Furthermore, pcdc2 was an inactive form that caused cell cycle arrest. (
   <bold>b</bold>) Both extracts could reduce high glucose level. Low cellular glucose significantly increased GAPDH phosphorylation via AMP-activated protein kinase (AMPK), triggering SIRT1 activation. This mechanism induced the cell cycle progression by decreasing Rb and cdc2 phosphorylation. High expression of proteins (
   <graphic xlink:href="pharmaceuticals-13-00283-i001" xmlns:xlink="http://www.w3.org/1999/xlink"/>); Low expression of proteins (
   <graphic xlink:href="pharmaceuticals-13-00283-i002" xmlns:xlink="http://www.w3.org/1999/xlink"/>); Hyperphosphorylation of proteins (
   <graphic xlink:href="pharmaceuticals-13-00283-i003" xmlns:xlink="http://www.w3.org/1999/xlink"/>); Hypophosphorylation of proteins (
   <graphic xlink:href="pharmaceuticals-13-00283-i004" xmlns:xlink="http://www.w3.org/1999/xlink"/>).
  </p>
 </caption>
 <graphic xlink:href="pharmaceuticals-13-00283-g010a" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 <graphic xlink:href="pharmaceuticals-13-00283-g010b" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
